Clinical Trials · NCT00257712

SMART: Somatotrophics, Memory, and Aging Research Trial

Phase
Phase 2
Recruitment status
Completed
Sponsor
University of Washington
Enrollment
151
Start date
Feb 2006
Locations
1 site, United States
Primary endpoint
Change in declarative memory, including total recall scores on three tests of memory and on dual task response time (RT), a test of executive function.
View Tesamorelin compound reference